ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer is the first in the Alinity hematology series of instruments to be commercially released, and is part of the planned integrated hematology system designed to address the productivity needs of the high-volume laboratory.
Hematology is a medical specialty dedicated to studying the physiology of blood, and the cause, diagnosis, treatment, and prevention of diseases related to blood. In diagnostics testing, hematology tests look at blood composition, which includes the identification and quantification of different types of blood cells. The Alinity hq analyzer automates the performance of these tests and reports on 29 different parameters within a matter of minutes.
"The Alinity hq launch is a key milestone for Abbott’s hematology business unit. Abbott is leading the way to providing a more efficient, complete lab solution that no competitor in the industry can match," said Luis de Luzuriaga, divisional vice president and general manager for Abbott’s hematology business. "With the Alinity family of harmonized systems, Abbott aims to simplify diagnostics testing across laboratory disciplines and help our customers improve patient outcomes."
Combining customer insights and engineering inspiration, Alinity hq was built from the ground up to help solve every day operational challenges and anticipated future needs for high-volume laboratories. Some unique capabilities of the system include:
Innovative, advanced optical technology combined with robust algorithms to handle normal and pathological samples
Design features that are intended to reduce manual steps and minimize errors, improve confidence in data and allow for uninterrupted operation
Scalable, modular design to customize configurations to better serve a broad spectrum of laboratories
Part of the Alinity family of harmonized systems, the Alinity hq analyzer has an intuitive user interface with iconography, color coding and reporting features shared by all Alinity instruments. The Alinity family also uses a common method for sample loading and reagent management, which helps labs simplify technician training.
To learn more about the Alinity hq analyzer and the Alinity family of harmonized systems visit corelaboratory.abbott/hematology.
Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostics platforms and simplify diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results.
The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics, along with Abbott’s AlinIQ—a first-of-its-kind, holistic suite of professional services that combines expertise with process analysis and informatics. Alinity is helping labs and hospital systems solve some of their most pressing challenges to deliver better patient care with fewer resources. To learn more, visit www.abbott.com/alinity.
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
*Note: Local product availability may vary depending on geographic location